Q1 2024 Theravance Biopharma Inc Earnings Call Transcript
Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance Biopharma first quarter 2024 conference call. (Operator instructions) Also, today's conference call is being recorded.
And now I would like to turn the call over to Rick Winningham, Chief Executive Officer. Please go ahead, sir.
Good afternoon, and welcome to Theravance Biopharma's first quarter 2024 earnings results conference call. On slide 2, you'll find our Safe Harbor language, and I'd remind everyone that our call today will include forward-looking statements involving risks and uncertainties pertaining to our development pipeline, expected benefits in our product candidate, anticipated timing of clinical trials, regulatory filings and expected financial results.
Information concerning factors that could cause results to differ materially from our forward-looking statements is described further in our filings with the SEC.
Now please turn to slide 3
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |